Edgewise Therapeutics, Inc. - Common Stock (EWTX)

Edgewise Therapeutics Inc is a biotechnology company focused on developing innovative treatments for muscle disorders, particularly those characterized by muscle weakness and atrophy

The company leverages its expertise in drug development to create novel therapeutic candidates that target underlying biological pathways involved in muscle function. By combining cutting-edge science with patient-focused approaches, Edgewise aims to address critical unmet medical needs in the realm of neuromuscular diseases, ultimately striving to improve the quality of life for patients affected by these conditions.